{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:11:06Z","timestamp":1781007066620,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004743"],"award-info":[{"award-number":["I01 BX004743"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurobiolaging.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:33:53Z","timestamp":1761982433000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting neuronal activity and neuroinflammation for the treatment of Alzheimer\u2019s disease in a mouse model"],"prefix":"10.1016","volume":"157","author":[{"given":"Chongzhen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio v.","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyonna F.","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-2134","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib1","unstructured":"Alzheimer's Association. Alzheimer's disease facts and figures. (2025)."},{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib2","unstructured":"Alzheimer's Study Group, A national Alzheimer's strategic plan: the report of the Alzheimer's study group.(2010)."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.10.006_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000063649","article-title":"Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?","volume":"71","author":"Carta","year":"2002","journal-title":"Psychother. Psychosom."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.10.006_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/2021.10.01.462640","article-title":"Systematic phenotyping and characterization of the 3xTg mouse model of Alzheimer\u2019s disease","volume":"15","author":"Javonillo","year":"2021","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.10.006_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JAD-2012-120640","article-title":"Novel disease-modifying therapies for Alzheimer's disease","volume":"31","author":"Jiang","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.10.006_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnen\/60.8.753","article-title":"Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption","volume":"60","author":"Le","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7945","key":"10.1016\/j.neurobiolaging.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-022-05484-5","article-title":"Social trauma engages lateral septum circuitry to occlude social reward","volume":"613","author":"Li","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.10.006_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"6301","key":"10.1016\/j.neurobiolaging.2025.10.006_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad8670","article-title":"Microglia development follows a stepwise program to regulate brain homeostasis","volume":"353","author":"Matcovitch-Natan","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"18","key":"10.1016\/j.neurobiolaging.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"issue":"31","key":"10.1016\/j.neurobiolaging.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","article-title":"Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy","volume":"25","author":"Spires","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.006_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.10.006_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/187152809789352249","article-title":"Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models","volume":"8","author":"Sugama","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nn1335","article-title":"Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches","volume":"7","author":"Tsai","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.10.006_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-4159.2007.05001.x","article-title":"Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line","volume":"104","author":"Udan","year":"2008","journal-title":"J. Neurochem."},{"issue":"22","key":"10.1016\/j.neurobiolaging.2025.10.006_bib22","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1073\/pnas.222433299","article-title":"Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease","volume":"99","author":"Urbanc","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2014.00042","article-title":"Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications","volume":"6","author":"Wang","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.006_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41467-017-02794-5","article-title":"Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.10.006_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.neurobiolaging.2010.05.004","article-title":"Carvedilol as a potential novel agent for the treatment of Alzheimer's disease","volume":"32","author":"Wang","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.10.006_bib26","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2018.05.027","article-title":"Loss of calretinin and parvalbumin positive interneurones in the hippocampal CA1 of aged Alzheimer\u2019s disease mice","volume":"681","author":"Zallo","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuint.2015.07.023","article-title":"Novel application of brain-targeting polyphenol compounds in sleep deprivation-induced cognitive dysfunction","volume":"89","author":"Zhao","year":"2015","journal-title":"Neurochem. Int."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:56:38Z","timestamp":1781006198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025001873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["S0197458025001873"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.10.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting neuronal activity and neuroinflammation for the treatment of Alzheimer\u2019s disease in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}